tetraethylammonium has been researched along with Buerger Disease in 3 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BUXTON, R | 1 |
| EICKHOFF, EC | 1 |
| CAMPBELL, KN | 1 |
| LYONS, RH | 1 |
| BOUNOUS, G | 2 |
| TATTONI, G | 2 |
3 other studies available for tetraethylammonium and Buerger Disease
| Article | Year |
|---|---|
Treatment of thromboangiitis obliterans and thrombophlebitis with tetraethylammonium chloride.
Topics: Humans; Systemic Vasculitis; Tetraethylammonium; Thromboangiitis Obliterans; Thrombophlebitis; Throm | 1948 |
Tetraethylammonium bromide in peripheral vascular disease and allied disorders; a new method of blocking the autonomic ganglia.
Topics: Anesthesia; Anesthesia, Conduction; Arteries; Arteriosclerosis Obliterans; Blood Vessels; Bromides; | 1946 |
[Effect of angiotrophin in the treatment of peripheral arteriosclerosis obliterans].
Topics: Arteriosclerosis Obliterans; Humans; Imidazoles; Kallikreins; Pancreatic Extracts; Tetraethylammoniu | 1956 |
[Effect of angiotrophin in the treatment of peripheral arteriosclerosis obliterans].
Topics: Arteriosclerosis Obliterans; Humans; Imidazoles; Kallikreins; Pancreatic Extracts; Tetraethylammoniu | 1956 |
[Effect of angiotrophin in the treatment of peripheral arteriosclerosis obliterans].
Topics: Arteriosclerosis Obliterans; Humans; Imidazoles; Kallikreins; Pancreatic Extracts; Tetraethylammoniu | 1956 |
[Effect of angiotrophin in the treatment of peripheral arteriosclerosis obliterans].
Topics: Arteriosclerosis Obliterans; Humans; Imidazoles; Kallikreins; Pancreatic Extracts; Tetraethylammoniu | 1956 |